Speaker
Mr. S. (Sebastiaan) Remmers
Authors
Remmers S.1, Beyer K.2, Prinsen P.3, Barletta F.4, Brunckhorst O.5, Gandaglia G.6, Smith E.J.7, Collette L.7, Evans-Axelsson S.8, N'Dow J.9, Roobol M.J.1, Van Hemelrijck M.2, Venderbos L.D.F.1
Institutions
1Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dept. of Urology, Rotterdam, The Netherlands, 2King’s College London, Translational Oncology and Urology Research, Faculty of Life Science of Medicine, London, United Kingdom, 3Netherlands Comprehensive Cancer Organization (IKNL), Dept. of Research and Development, Eindhoven, The Netherlands, 4IRCCS San Raffaele Scientific Institute, Dept. Urology, Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, Milan, Italy, 5King’s College London, Guy’s Hospital Campus, MRC Centre for Transplantation, London, United Kingdom, 6IRCCS San Raffaele Scientific Institute, Dept. of Urology, Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, Milan, Italy, 7European Association of Urology, Guidelines Office, Arnhem, The Netherlands, 8Bayer AB, Dept. of Medical Affairs Oncology, Stockholm, Sweden, 9University of Aberdeen, Academic Urology Unit, Aberdeen, United Kingdom
Event
38th Annual EAU Congress
Date – Time -
Location
12 March 2023, 10:45
-
12:15,
Yellow Area, Brown 2
Session
Abstract Session 21 -
Functional outcome after prostatectomy: Challenges and solutions
Topic
Prostate Cancer, Localised - Follow up, Quality of life / Patient reported outcomes